hydroxyproline has been researched along with batimastat in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boichot, E; Caulet-Maugendre, S; Corbel, M; Germain, N; Lagente, V; Molet, S | 1 |
de Hingh, IH; de Man, BM; Hendriks, T; Lomme, RM; Siemonsma, MA | 1 |
2 other study(ies) available for hydroxyproline and batimastat
Article | Year |
---|---|
Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat.
Topics: Animals; Bleomycin; Body Weight; Bronchoalveolar Lavage Fluid; Cell Count; Hydroxyproline; Male; Matrix Metalloproteinase Inhibitors; Metalloendopeptidases; Mice; Mice, Inbred Strains; Phenylalanine; Protease Inhibitors; Pulmonary Fibrosis; Survival Rate; Thiophenes; Tissue Inhibitor of Metalloproteinases | 2001 |
The matrix metalloproteinase inhibitor BB-94 improves the strength of intestinal anastomoses in the rat.
Topics: Anastomosis, Surgical; Animals; Colon; Hydroxyproline; Ileum; Male; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Models, Animal; Phenylalanine; Postoperative Period; Protease Inhibitors; Rats; Rats, Wistar; Thiophenes; Time Factors; Treatment Outcome | 2002 |